197 related articles for article (PubMed ID: 36050418)
1. Paraneoplastic neurological syndromes associated with renal or bladder cancer: case series and PRISMA-IPD systematic review.
Villagrán-García M; Muñiz-Castrillo S; Ciano-Petersen NL; Vogrig A; Farina A; Villard M; Psimaras D; Alentorn A; Gonçalves D; Fabien N; Rogemond V; Joubert B; Honnorat J
J Neurol; 2023 Jan; 270(1):283-299. PubMed ID: 36050418
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
[TBL] [Abstract][Full Text] [Related]
3. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
4. The association between paraneoplastic neurological syndromes (PNS) and urothelial carcinoma - A review of the literature.
Otis SU; Banna GL; Maniam A
Crit Rev Oncol Hematol; 2024 Apr; 196():104314. PubMed ID: 38447785
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.
Storstein A; Raspotnig M; Vitaliani R; Giometto B; Graus F; Grisold W; Honnorat J; Vedeler CA
J Neurol; 2016 May; 263(5):1001-1007. PubMed ID: 27007485
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic neurological syndromes: unusual presentations of cancer. A practical review.
Braik T; Evans AT; Telfer M; McDunn S
Am J Med Sci; 2010 Oct; 340(4):301-8. PubMed ID: 20460982
[TBL] [Abstract][Full Text] [Related]
7. Rare and changeable as a chameleon: paraneoplastic syndromes in renal cell carcinoma.
Hegemann M; Kroeger N; Stenzl A; Bedke J
World J Urol; 2018 Jun; 36(6):849-854. PubMed ID: 29429069
[TBL] [Abstract][Full Text] [Related]
8. [Clinical features of urological malignancies with paraneoplastic syndromes].
Yang Y; Mao QZ; Li HZ; Rong S; Yan WG; Ji ZG; Liu GH; Xu WF; Xiao H; Wang HJ
Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(48):3411-4. PubMed ID: 21223815
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of paraneoplastic neurological syndromes: a population-based study.
Vogrig A; Gigli GL; Segatti S; Corazza E; Marini A; Bernardini A; Valent F; Fabris M; Curcio F; Brigo F; Iacono D; Passadore P; Rana M; Honnorat J; Valente M
J Neurol; 2020 Jan; 267(1):26-35. PubMed ID: 31552550
[TBL] [Abstract][Full Text] [Related]
10. SOX1 antibody-related paraneoplastic neurological syndromes: clinical correlates and assessment of laboratory diagnostic techniques.
Vabanesi M; Pinto AL; Vogrig A; Goncalves D; Rogemond V; Joubert B; Fabien N; Honnorat J; Muñiz-Castrillo S
J Neurol; 2023 Mar; 270(3):1691-1701. PubMed ID: 36512064
[TBL] [Abstract][Full Text] [Related]
11. Incidence and clinical relevance of paraneoplastic syndromes in patients with renal cell carcinoma.
Moldovan T; Boynton D; Kuperus J; Parker J; Noyes SL; Brede CM; Tobert CM; Lane BR
Urol Oncol; 2023 Sep; 41(9):392.e11-392.e17. PubMed ID: 37537025
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic neurological syndromes associated with non-Hodgkin lymphoma: a case series.
Dinoto A; Cheli M; Catalan M; Olivo S; Scali I; Bertolotti C; Sartori A; Manganotti P
Neurol Sci; 2022 Mar; 43(3):2077-2079. PubMed ID: 35000013
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy.
Moreira DM; Gershman B; Lohse CM; Boorjian SA; Cheville JC; Leibovich BC; Thompson RH
World J Urol; 2016 Oct; 34(10):1465-72. PubMed ID: 26914818
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic neurological syndromes and onconeural antibodies: clinical and immunological aspects.
Storstein A; Vedeler CA
Adv Clin Chem; 2007; 44():143-85. PubMed ID: 17682342
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic syndromes and oncological outcomes in renal cancer.
Ikuerowo SO; Ojewuyi OO; Omisanjo OA; Abolarinwa AA; Bioku MJ; Doherty AF
Niger J Clin Pract; 2019 Sep; 22(9):1271-1275. PubMed ID: 31489865
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic neurological syndromes.
Honnorat J; Antoine JC
Orphanet J Rare Dis; 2007 May; 2():22. PubMed ID: 17480225
[TBL] [Abstract][Full Text] [Related]
17. A single center retrospective study of paraneoplastic neurological syndromes with positive onconeural antibodies.
Fu P; He L; Tang N; Nie Q; Li Z
J Clin Neurosci; 2021 Jul; 89():336-342. PubMed ID: 34119290
[TBL] [Abstract][Full Text] [Related]
18. Myasthenia gravis associated with renal cell carcinoma: a paraneoplastic syndrome or just a coincidence.
Zheng Y; Luo J; Jin H; Liu R; Hao H; Gao F
BMC Neurol; 2021 Jul; 21(1):277. PubMed ID: 34253185
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study.
Oliveira V; Videira G; Samões R; Carneiro P; Neves E; Santos E
J Neurol Sci; 2020 Nov; 418():117103. PubMed ID: 32877801
[TBL] [Abstract][Full Text] [Related]
20. Severe central and peripheral paraneoplastic demyelination associated with tumours of the ovaries.
Jurkiewicz E; Kotulska K; Nowak K; Malczyk K; Borkowska J; Bilska M
Childs Nerv Syst; 2015 Sep; 31(9):1601-6. PubMed ID: 25966874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]